Highbridge Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-142,280
| Closed | -$18.8M | – | 336 |
|
2025
Q1 | $18.8M | Buy |
+142,280
| New | +$18.8M | 0.76% | 41 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 1219 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 1172 |
|
2017
Q2 | – | Sell |
-49,407
| Closed | -$803K | – | 1249 |
|
2017
Q1 | $803K | Buy |
49,407
+38,425
| +350% | +$625K | 0.01% | 576 |
|
2016
Q4 | $166K | Buy |
+10,982
| New | +$166K | ﹤0.01% | 922 |
|
2016
Q2 | – | Sell |
-8,676
| Closed | -$241K | – | 1344 |
|
2016
Q1 | $241K | Buy |
+8,676
| New | +$241K | ﹤0.01% | 690 |
|
2015
Q4 | – | Sell |
-254,176
| Closed | -$10.2M | – | 1168 |
|
2015
Q3 | $10.2M | Buy |
+254,176
| New | +$10.2M | 0.16% | 162 |
|